Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) to Present Company Overview at the Needham Annual Healthcare Conference

Published: Apr 22, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CAMBRIDGE, MA--(Marketwired - April 18, 2013) - Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the Needham & Company Annual Healthcare Conference in New York, NY on Tuesday, April 30, 2013 at 4:20 p.m. Eastern Time. Chris Garabedian, Sarepta's president and CEO, will be the presenter.

The presentation will be webcast live under the investor relations section of Sarepta Therapeutics' website at and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics

Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy, as well as potential treatments for some of the world's most lethal infectious diseases. Sarepta aims to build a leading, independent biotech company dedicated to translating its RNA-based science into transformational therapeutics for patients who face significant unmet medical needs. For more information, please visit us at

Sarepta Investor Contact:
Erin Cox
Email Contact

Sarepta Media Contact:
Jim Baker
Email Contact

Help employers find you! Check out all the jobs and post your resume.

Back to news